Digital GenAI and the revolution of drug development Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.
R&D Sponsored Reinventing R&D in the age of AI - How intelligent technolog... Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophisticated understanding of human
News Industry steps up as EU debates an action plan for AI Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.
Digital JP Morgan Week 2025 – Trân Lê and Sohit Gatiganti pharmaphorum sits down for a quick chat with the Grove.AI team about their new AI agent for clinical trial recruitment.
Sales & Marketing Partner Content AI Literacy for Pharma Marketing Career Success Preparing for AI Success in 2025 and Beyond: Insights from Our 2024 Research.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.